Michael D. Abramoff, MD, PhD, explores lessons learned during the creation and commercialization of a new industry in healthcare, highlighting LumineticsCore™ (formerly known as IDx-DR), the first fully autonomous AI diagnostic system De Novo cleared by the FDA. Find out how Digital Diagnostics collaborates with patient advocacy groups, federal regulators, and other quality of care and ethics-focused stakeholders to pave the way for autonomous AI diagnosis to become the new standard of care, contributing to democratizing healthcare and closing care gaps.